Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
170730-06-0 | 7-Acetyl-2,3-dihydrobenzofuran | AA00HZDE | MFCD11656624
175424-31-4 | 5-Bromo-1-methyl-1h,2h,3h-pyrrolo[2,3-b]pyridin-2-one | AA00HZLI | MFCD22394552
179011-40-6 | 1-(benzyloxy)-2,4-difluoro-5-nitrobenzene | AA00HZUF | MFCD29043665
1806770-16-0 | 2-Bromo-4-(difluoromethyl)-3-fluoropyridine | AA00I02S | MFCD25477690
1807539-10-1 | Acid-peg2-ss-peg2-acid | AA00I06G | MFCD28950760
1820612-66-5 | 5-Bromo-3-chloro-6-hydroxypyridine-2-carboxylic acid | AA00I0FS | MFCD28369617
1820674-57-4 | 3-Bromo-5-(dimethylamino)-1-methylpyrazin-2-one | AA00I0P8 | MFCD26131165
1820706-98-6 | 3-Amino-2-methylphenyl triflate | AA00I0VO | MFCD26407437
1823231-98-6 | Benzyl ethyl(tetrahydro-2h-pyran-4-yl)carbamate | AA00I14R | MFCD18206015
18385-82-5 | 7-Bromochroman-4-ol | AA00I1CX | MFCD23806968